It’s too early. It’s really going to depend on the opening up of those countries. It’s a trend that you can anticipate in every country. It’s domestic demand that’s going to be impacted first, even in European countries. French people will discover places around their homes and, in every country, I think that the behavior will be like that, initially. In terms of international travel, the airline sector has been hit so much that the reboot strategies of each airline company is going to be very interesting to follow but I absolutely don’t expect that to go back to what it was, previously, for at least two years.
Again, during SARS, within one month, after Hong Kong was declared SARS free – because SARS started in Hong Kong – the travel market and the hotel occupancies rebounded back to 70%. The SARS impact was more local than global, compared to Covid. The impact, in terms of cost, was much lower. Somehow, the rapidity with which the contagion was controlled was much quicker and, I believe, that in people’s minds, it was pretty much a Hong Kong and China thing considering that, at that time, the level of communication and the level of transparency was definitely much lower than what it has been this time around.
I think both are comparable, to some extent, but totally incomparable, in terms of impact and recovery scenarios and strategies. I can think of one very simple thing. At that time, the hand sanitizing products, in Hong Kong, were put in all public toilets, in all malls, in all hotels and they were supposed to be extended to mainland China. One year after, you would go to China and there would be no hand sanitizer anywhere, simply because of the owner’s pressure to contain costs and they considered that that kind of expense was unnecessary.
Absolutely, yes.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities.
© 2024 IP 1 Ltd. All rights reserved.